August 28, 2025
aXichem AB (publ), delårsrapport januari – juni 2025
aXichems utveckling under perioden 2025-01-01—2025-06-30 I denna delårsrapport presenteras koncernen
Read the article here
We create value.
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
AXICHEM A
(AXIC A)
3.5
SEK
0.4 / 12.9%
High
3.6
Low
3.2
Volume
116927
Turnover
390155.02
August 29, 2025 17:29:47
Financial Reports
August 28, 2025
aXichem AB (publ), Interim Report January – June 2025
aXichem’s development during the period 2025-01-01—2025-06-30 In this interim report,
Read the article here
May 28, 2025
aXichem AB (publ) publicerar Årsredovisning 2024
aXichem AB (publ), som utvecklar innovativa naturanaloga fodertillsatser och kosttillskottsingredienser,
Read the article here
May 28, 2025
aXichem AB (publ) publishes Annual Report 2024
aXichem AB (publ), the developer of innovative natural analogue feed
Read the article here
May 22, 2025
aXichem AB (publ), delårsrapport januari – mars 2025
aXichems utveckling under perioden 2025-01-01—2025-03-31 I denna delårsrapport presenteras koncernen
Read the article here
May 22, 2025
aXichem AB (publ), Interim Report January – March 2025
aXichem’s development during the period 2025-01-01—2025-03-31 In this interim report,
Read the article here
February 27, 2025
aXichem AB (publ) Bokslutskommuniké, januari – december 2024
aXichems utveckling under perioden 2024-01-01—2024-12-31 I denna delårsrapport presenteras koncernen
Read the article here
February 27, 2025
aXichem AB (publ) Year End Report, January – December 2024
aXichem’s development during the period 2024-01-01—2024-12-31 In this interim report,
Read the article here
Financial Calendar
Year-end report 2024 - 27 February 2025
Q1 Report, Jan – March 2025 - 22 May 2025
Annual Report 2024 - 28 May 2025
Annual General Meeting - 18 June 2025
Q2 Report, Jan – June 2025 - 28 August 2025
Q3 Report, Jan – Sept 2025 - 28 November 2025
Year End Report 2025 - 26 February 2026
Press releases
August 28, 2025
aXichem AB (publ), delårsrapport januari – juni 2025
aXichems utveckling under perioden 2025-01-01—2025-06-30 I denna delårsrapport presenteras koncernen
Read the article here
August 28, 2025
aXichem AB (publ), Interim Report January – June 2025
aXichem’s development during the period 2025-01-01—2025-06-30 In this interim report,
Read the article here
August 25, 2025
aXichems VD Torsten Helsing presenterar rapport för andra kvartalet 2025 i en direktsänd webbkonferens
aXichem AB (publ), offentliggör sin rapport för andra kvartalet 2025
Read the article here
August 25, 2025
aXichem’s CEO Torsten Helsing Presents the Report for the Second Quarter 2025 in a Live Web Conference
aXichem AB (publ), publishes its report for the second quarter
Read the article here
August 25, 2025
aXichem lämnar in patentansökan för phenylcapsaicin som tillsats i foder för mjölkkor
aXichem AB (publ), (aXichem), som utvecklar naturanaloga fodertillsatser och kosttillskottsingredienser,
Read the article here
August 25, 2025
aXichem files patent application for phenylcapsaicin as a feed additive for dairy cattle
aXichem AB (publ), (aXichem), a developer of innovative natural analogue
Read the article here
August 21, 2025
Rättelse av pressmeddelande: aXichem tillkännager första kommersiella ordern för aXiphen från en kycklingproducent i Brasilien
Rättelsen avser svensk version: ”Ordern representerar en kommersiell och storskalig
Read the article here
August 21, 2025
aXichem tillkännager första kommersiella ordern för aXiphen från en kycklingproducent i Brasilien
aXichem AB (publ), (aXichem), som utvecklar som utvecklar naturanaloga fodertillsatser
Read the article here
August 21, 2025
aXichem announces first commercial order for aXiphen from a poultry producer in Brazil
aXichem AB (publ), (aXichem), a developer of innovative natural analogue
Read the article here
July 14, 2025
aXichem stärker patentportföljen med första nationella patentet för aXivite inom kosttillskott för sportprestationer
aXichem AB (publ), (aXichem), som utvecklar innovativa kosttillskottsingredienser, har erhållit
Read the article here
July 14, 2025
aXichem Strengthens its Patent Portfolio with First National Patent for aXivite in Supplements for Sports Performance
aXichem AB (publ), (aXichem), the developer of innovative food supplement
Read the article here
July 01, 2025
aXichem submits complementary information for authorization in EU of phenylcapsaicin as a zootechnical feed additive for chickens for fattening
aXichem AB (publ), (aXichem), a developer of innovative natural analogue
Read the article here
July 01, 2025
aXichem lämnar in kompletterande information för godkännande i EU av phenylcapsaicin som zooteknisk fodertillsats för slaktkycklingar
aXichem AB (publ), (aXichem), som utvecklar innovativa fodertillsatser och kosttillskottsingredienser,
Read the article here
June 18, 2025
Kommuniké från årsstämma 2025 i aXichem AB (publ)
aXichem AB (publ), org.nr 556739-8663 (”Bolaget”), höll årsstämma onsdagen den
Read the article here
June 18, 2025
Resolutions from the 2025 Annual General Meeting of aXichem AB (publ)
aXichem AB (publ), corporate registration number 556739-8663 (the “Company”), held
Read the article here
June 18, 2025
aXichem AB (publ) publishes the English translation of its Annual Report 2024
aXichem AB (publ), announces that the English translation of the
Read the article here
June 18, 2025
aXichem AB (publ) publicerar engelsk översättning av Årsredovisning 2024
aXichem AB (publ), meddelar att bolagets Årsredovisning 2024 nu finns
Read the article here
June 12, 2025
aXichem announces positive results of completed efficacy studies, as well as time for submission of supplemented Feed Additive application in the EU
aXichem AB (publ), developer of innovative natural analogue feed additives
Read the article here
June 12, 2025
aXichem meddelar positiva resultat av genomförda effektstudier, samt tid för inlämning av kompletterad Feed Additive-ansökan i EU
aXichem AB (publ), som utvecklar naturanaloga foder- och kosttillskottsingredienser, meddelar
Read the article here
May 28, 2025
aXichem AB (publ) publicerar Årsredovisning 2024
aXichem AB (publ), som utvecklar innovativa naturanaloga fodertillsatser och kosttillskottsingredienser,
Read the article here
May 28, 2025
aXichem AB (publ) publishes Annual Report 2024
aXichem AB (publ), the developer of innovative natural analogue feed
Read the article here
May 22, 2025
aXichem AB (publ), delårsrapport januari – mars 2025
aXichems utveckling under perioden 2025-01-01—2025-03-31 I denna delårsrapport presenteras koncernen
Read the article here
May 22, 2025
aXichem AB (publ), Interim Report January – March 2025
aXichem’s development during the period 2025-01-01—2025-03-31 In this interim report,
Read the article here
May 19, 2025
aXichems VD Torsten Helsing presenterar rapport för första kvartalet 2025 i en direktsänd webbkonferens
aXichem AB (publ), offentliggör sin rapport för första kvartalet 2025
Read the article here
May 19, 2025
aXichem’s CEO Torsten Helsing Presents the Report for the First Quarter 2025 in a Live Web Conference
aXichem AB (publ), publishes its report for the first quarter
Read the article here
May 16, 2025
KALLELSE TILL ÅRSSTÄMMA I AXICHEM AB (PUBL)
Aktieägarna i aXichem AB (publ) kallas till årsstämma onsdagen den
Read the article here
May 16, 2025
NOTICE OF ANNUAL GENERAL MEETING IN AXICHEM AB (PUBL)
The shareholders in aXichem AB (publ) are hereby convened to
Read the article here
May 12, 2025
aXichem receives first call-off order for aXiphen[ ]from Chr. Olesen after successful tests in Brazil
aXichem AB (publ), (aXichem), the developer of innovative feed additives
Read the article here
May 12, 2025
aXichem får första avropsordern för aXiphen från Chr. Olesen efter framgångsrika tester i Brasilien
aXichem AB (publ), (aXichem), som utvecklar innovativa fodertillsatser och kosttillskottsingredienser,
Read the article here
April 28, 2025
aXivite driver rekordefterfrågan då Triquetra Healths GLP-Activate[™] klättrar till toppförsäljning
aXichem AB (publ), (aXichem), som utvecklar innovativa naturanaloga fodertillsatser och
Read the article here
April 28, 2025
aXivite fuels record demand as Triquetra Health’s GLP-Activate[™] climbs to top-seller status
aXichem AB (publ), (aXichem), the developer of innovative natural analogue
Read the article here
April 16, 2025
aXichem utser Erik Lager till Chief Operating Officer, för att möta tillväxtfasens ökade behov av en kvalitetssäkrad leveransprocess
aXichem AB (publ), (aXichem), som utvecklar naturanaloga fodertillsatser och kosttillskottsingredienser,
Read the article here
April 16, 2025
aXichem appoints Erik Lager as Chief Operating Officer, to meet the growth phase’s increased need for a quality-assured delivery process
aXichem AB (publ), (aXichem), developer of innovative natural analogue feed
Read the article here
March 18, 2025
aXichem upptar kreditfacilitet med stöd från EIF, för fortsatt etablering av aXiphen i Brasilien
aXichem AB (publ), (aXichem), som utvecklar naturanaloga fodertillsatser och kosttillskottsingredienser,
Read the article here
March 18, 2025
aXichem takes up credit facility with support from EIF, for continued establishment of aXiphen in Brazil
aXichem AB (publ), (aXichem), developer of innovative natural analogue feed
Read the article here
March 05, 2025
aXichem meddelar preliminära resultat från CrossFit Performance-studie med aXivite, indikerande avsevärd förbättring av uthållighet och återhämtning
aXichem AB (publ), (aXichem), som utvecklar innovativa naturanaloga fodertillsatser och
Read the article here
March 05, 2025
aXichem Announces Preliminary Findings from CrossFit Performance Study with aXivite, Indicating Unmatched Endurance and Recovery Gains
aXichem AB (publ), (aXichem), the developer of innovative natural analogue
Read the article here
February 27, 2025
aXichem AB (publ) Bokslutskommuniké, januari – december 2024
aXichems utveckling under perioden 2024-01-01—2024-12-31 I denna delårsrapport presenteras koncernen
Read the article here
February 27, 2025
aXichem AB (publ) Year End Report, January – December 2024
aXichem’s development during the period 2024-01-01—2024-12-31 In this interim report,
Read the article here
February 25, 2025
aXichem’s CEO Torsten Helsing Presents the Year End Report 2024 in a Live Web Conference
aXichem AB (publ), publishes its Year End Report for 2024
Read the article here
February 25, 2025
aXichems VD Torsten Helsing presenterar bokslutskommuniké 2024 i en direktsänd webbkonferens
aXichem AB (publ), offentliggör sin bokslutskommuniké för 2024 torsdagen den
Read the article here
February 12, 2025
aXichem erhåller order från Chr. Olesen avseende aXiphen till ett värde av cirka 7 miljoner kronor
aXichem AB (publ), (aXichem), som utvecklar som utvecklar naturanaloga fodertillsatser
Read the article here
February 12, 2025
aXichem receives order from Chr. Olesen regarding aXiphen to a value of approximately SEK 7 million
aXichem AB (publ), (aXichem), the developer of innovative natural analogue
Read the article here
February 04, 2025
aXichem uppdaterar status för komplettering av Feed Additive-ansökan i EU för phenylcapsaicin
aXichem AB (publ), som utvecklar naturanaloga foder- och kosttillskottsingredienser, meddelar
Read the article here
February 04, 2025
aXichem updates status regarding completion of Feed Additive application in the EU for phenylcapsaicin
aXichem AB (publ), developer of innovative natural analogue feed additives
Read the article here
Commissioned Research
Company description
We draw from the genius of nature and respect nature in return.
aXichem Bolagsbeskrivning 131121
PDF 1.28 MB
Certified Advisor
Västra Hamnen Corporate Finance
Jungmansgatan 12
211 11 Malmö
General Meetings Archive
Investor Structure
aXichem’s ten largest owners according to the shareholders’ register kept by Euroclear as of 2025-06-30.
Total number of shares: 59 114 905.
| Name | Participating interest (%) |
| LMK-bolagen | 16,4 |
| Nordnet Pensionsförsäkring AB | 7,70 |
| Manakin Ltd | 6,11 |
| Avanza Pension | 5,93 |
| Pierre Sahlstrand | 4,72 |
| Futur | 3,40 |
| Aksjesel. Arbejdenes Landsbank | 3,36 |
| Christian Månsson | 2,47 |
| Sydbank | 2,12 |
| Ingemar Claesson | 1,78 |
Investor enquiries
Subscribe to information from aXichem